65184-39-6 Usage
Uses
Used in Pharmaceutical Industry:
5-Acetylpyridine-2-carboxylic acid is used as a key intermediate for the synthesis of various pharmaceuticals, contributing to the development of new drugs with improved therapeutic properties.
Used in Agrochemical Industry:
5-Acetylpyridine-2-carboxylic acid is used as a precursor in the production of agrochemicals, helping to create effective solutions for agricultural applications.
Used in Anti-inflammatory Applications:
5-Acetylpyridine-2-carboxylic acid is used as a precursor in the development of anti-inflammatory drugs, potentially offering new treatment options for inflammatory conditions.
Used in Anti-cancer Applications:
5-Acetylpyridine-2-carboxylic acid is used as a precursor in the production of bioactive molecules with anti-cancer properties, aiding in the discovery of novel therapeutic agents for cancer treatment.
Used in Research and Development:
5-Acetylpyridine-2-carboxylic acid is used as a valuable tool for researchers studying the structure-activity relationships of various chemical compounds, enabling the advancement of scientific knowledge and the development of innovative applications.
Check Digit Verification of cas no
The CAS Registry Mumber 65184-39-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,5,1,8 and 4 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 65184-39:
(7*6)+(6*5)+(5*1)+(4*8)+(3*4)+(2*3)+(1*9)=136
136 % 10 = 6
So 65184-39-6 is a valid CAS Registry Number.
65184-39-6Relevant articles and documents
Iminothiadiazine Dioxide Compounds as BACE Inhibitors, Compositions and Their Use
-
Paragraph 0578, (2015/11/16)
In its many embodiments, the present invention provides certain iminothiadiazine dioxide compounds, including compounds Formula (I): and include stereoisomers thereof, and pharmaceutically acceptable salts of said compounds stereoisomers, wherein each of R1, R2, R3, R4, R5, R9, ring A, ring B, m, n, p, -L1-, -L2-, and -L3- is selected independently and as defined herein. The novel iminothiadiazine dioxide compounds of the invention have surprisingly been found to exhibit properties which are expected to render them advantageous as BACE inhibitors and/or for the treatment and prevention of various pathologies related to β-amyloid (“Aβ”) production. Pharmaceutical compositions comprising one or more such compounds (alone and in combination with one or more other active agents), and methods for their preparation and use in treating pathologies associated with amyloid beta (Aβ) protein, including Alzheimer's disease, are also disclosed.
